Endo International plc – (NASDAQ:ENDP) (TSE:ENL) saw a large decline in short interest in December. As of December 29th, there was short interest totalling 20,250,569 shares, a decline of 13.5% from the December 15th total of 23,402,027 shares. Currently, 10.1% of the shares of the stock are sold short. Based on an average daily trading volume, of 3,647,667 shares, the days-to-cover ratio is currently 5.6 days.
A number of large investors have recently modified their holdings of the stock. Teachers Advisors LLC grew its holdings in Endo International by 1.9% during the 2nd quarter. Teachers Advisors LLC now owns 840,470 shares of the company’s stock valued at $9,388,000 after purchasing an additional 15,928 shares during the last quarter. Diamond Hill Capital Management Inc. grew its holdings in Endo International by 46.8% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 716,670 shares of the company’s stock valued at $6,138,000 after purchasing an additional 228,426 shares during the last quarter. TIAA CREF Investment Management LLC grew its holdings in Endo International by 1.6% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 649,535 shares of the company’s stock valued at $7,255,000 after purchasing an additional 10,387 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in Endo International by 4.9% during the 2nd quarter. Ameriprise Financial Inc. now owns 581,552 shares of the company’s stock valued at $6,497,000 after purchasing an additional 27,414 shares during the last quarter. Finally, Parametric Portfolio Associates LLC grew its holdings in Endo International by 18.7% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 398,099 shares of the company’s stock valued at $4,447,000 after purchasing an additional 62,822 shares during the last quarter. Institutional investors own 93.06% of the company’s stock.
ENDP has been the topic of a number of analyst reports. Zacks Investment Research upgraded shares of Endo International from a “hold” rating to a “buy” rating and set a $9.75 target price on the stock in a research note on Wednesday, October 11th. Mizuho restated a “buy” rating on shares of Endo International in a research note on Friday, November 10th. Cantor Fitzgerald set a $9.00 price target on shares of Endo International and gave the stock a “hold” rating in a research note on Monday, October 30th. Royal Bank of Canada decreased their price target on shares of Endo International from $9.00 to $8.00 and set a “sector perform” rating on the stock in a research note on Friday, November 10th. Finally, BidaskClub upgraded shares of Endo International from a “sell” rating to a “hold” rating in a research note on Tuesday, December 12th. Three investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Hold” and an average price target of $11.27.
Shares of Endo International (ENDP) opened at $7.95 on Friday. The company has a current ratio of 1.08, a quick ratio of 0.86 and a debt-to-equity ratio of 10.78. The stock has a market cap of $1,770.00, a PE ratio of -0.41, a PEG ratio of 2.98 and a beta of 0.59. Endo International has a 1 year low of $5.77 and a 1 year high of $14.45.
Endo International (NASDAQ:ENDP) (TSE:ENL) last announced its earnings results on Thursday, November 9th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.06. The firm had revenue of $786.90 million for the quarter, compared to analysts’ expectations of $794.93 million. Endo International had a negative net margin of 126.97% and a positive return on equity of 66.98%. The business’s revenue was down 11.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.01 EPS. sell-side analysts anticipate that Endo International will post 3.67 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Endo International plc – (ENDP) Sees Large Decrease in Short Interest” was first posted by Stock Observer and is the sole property of of Stock Observer. If you are reading this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be viewed at https://www.thestockobserver.com/2018/01/13/endo-international-plc-endp-sees-large-decrease-in-short-interest.html.
About Endo International
Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.